Author

Anders Dige 1

1 Aarhus University Hospital,Aarhus,Denmark

CLINICAL TRIAL: HIGH-DOSE VITAMIN D TREATMENT TO CROHN'S DISEASE PATIENTS WITH DISEASE ACTIVITY, A RANDOMIZED PLACEBO-CONTROLLED DOUBLE-BLINDED STUDY (MIRVIDIC)

Mia Bendix, Anders Dige, Søren Peter Jørgensen, Jens Frederik Dahlerup, Bent Deleuran, Jørgen Agnholt

Combination of biomarkers reflecting type IV collagen degradation and citrullinated vimentin predicts response to adalimumab with high diagnostic accuracy, in patients with Crohn's disease

Joachim Høg Mortensen, Morten Asser Karsdal, Henning Grønbæk, Christian Lodberg Hvas, Anders Dige, Tina Manon-Jensen

DIETARY INTERVENTION WITH A DIET RICH IN ARABINOXYLANS AND RESISTANT STARCH MODULATES T-CELL ACTIVATION ESTIMATED BY CD25 EXPRESSION IN METABOLIC SYNDROME

Stine Hald, Anders Kirch Dige, Sidsel Stoy, Mia Bendix, Anne Grethe Schioldan, Kjeld Hermansen, Søren Gregersen, Knud Erik Bach Knudsen, Jørgen Agnholt, Jens Frederik Dahlerup, Anders Dige

EFFECTS OF ANTI-TNF-Α AND STEROID TREATMENT ON MACROPHAGE ACTIVATION ESTIMATED BY SOLUBLE CD163 LEVELS IN INFLAMMATORY BOWEL DISEASE

Anders Kirch Dige, Sidsel Stoy, Karen Louise Thomsen, Christian Lodberg Hvas, Jørgen Agnholt, Holger Jon Moeller, Henning Grønbæk, Anders Dige, Christian Lodberg Hvas

Seven weeks high-dose vitamin D treatment in Crohn's disease reduces the need for intensified infliximab treatment during 52 weeks follow up

Mia Bendix, Anders Dige, Søren Peter Jørgensen, Jens Frederik Dahlerup, Bo Martin Bibby, Bent Deleuran, Jørgen Agnholt

THE INTESTINAL ENVIRONMENT OF PATIENTS WITH ULCERATIVE COLITIS IMPAIRS THE ABILITY OF MACROPHAGE AND DENDRITIC CELL SUBSETS TO PRODUCE RETINOIC ACID

Maria K. Magnusson, Siggeir Brynjólfsson, Anders Dige, Lena Öhman, Lars Börjesson, Jørgen Agnholt, Henrik Sjovall, Mary Wick

Item 1 - 6 / 8
1